TSNDF

0.30029.93%
CA

Craig Alexander Collard

Lead Independent Director

Mr. Craig Alexander Collard serves as Chief Executive Officer at Heron Therapeutics, Inc. since April 3, 2023 and its Director since February 2023. He had been Chief Executive Officer of Veloxis Pharmaceuticals, Inc. since December 2015 until 2022. Mr. Collard joined Veloxis in December 2015. He has been Independent Director at TerrAscend Corp. since December 6, 2018 and serves as its Lead Independent Director since 2021. Mr. Collard is a Member of the Board of Directors of Veloxis. He served as Independent Director of Opiant Pharmaceuticals, Inc. since October 29, 2018 and served as its Chairman since January 1, 2021. He had been Chief Executive Officer and President of Veloxis Pharmaceuticals A/S since December 10, 2015 until 2022. Mr. Collard founded Carolina Pharmaceuticals, Inc. in May 2005 and served as its Chief Executive Officer & President since June 2003. In 2003, Mr. Collard founded Cornerstone Therapeutics, Inc. (now known as Chiesi USA, Inc.). He served as Chairman of Cornerstone Therapeutics Inc. from October 31, 2008 to February 2014 and served as its Chief Executive Officer from October 31, 2008 until February 2014. Mr. Collard founded Cornerstone BioPharma Holdings, Inc. (formerly Cornerstone BioPharma Holdings, Ltd.), in 2004 and served as its Chief Executive Officer and President from March 2004 to October 2008. He founded Cornerstone Therapeutics Inc. in August 2004 and served as its Interim Principal Financial Officer from July 2010 to February 1, 2011. He served as President of Cornerstone Therapeutics Inc., since October 2008 until September 6, 2011. Mr. Collard served as Chief Executive Officer of Critical Therapeutics Inc. He served as the Vice President, Sales of Verum Pharmaceuticals from August 2002 to February 2003. He served as a Director of Carolina Pharmaceuticals, Inc. From 1998 to 2003, he served as Director of National Accounts at start up company, DJ Pharma, which was eventually purchased by Biovail Pharmaceuticals, Inc. He served as Chairman of Critical Therapeutics Inc. He serves as a Director of Biomarck Pharmaceuticals, Ltd. He was a Director of Hilltop Home Inc. for severely-handicapped children from 2005 to 2015. He has been a Director of Cornerstone Therapeutics Inc. since October 2008. He served as a Director of Auriga Laboratories Inc. and Critical Therapeutics Inc. His pharmaceutical career began in 1992 as a field sales Representative at Dura Pharmaceuticals, Inc. Mr. Collard is a Member of the Board of Directors of Biomark Pharmaceuticals, Inc., Hilltop Home Foundation, as well as the Triangle Chapter of the Cystic Fibrosis Foundation. He was Director at Sierra Oncology, Inc. since May 26, 2020 until July 01, 2022. Mr. Collard holds a B.S. in Engineering from the Southern College of Technology (now Southern Polytechnic State University).

公司職務